Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report.

Literature DB >> 2126264

Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report.

Abstract

This is a single-case report of fluvoxamine treatment of comorbid autistic disorder (AD) and obsessive-compulsive disorder (OCD). Psychological, neuroanatomical, and neurochemical parallels are drawn between AD and OCD. The implications of this case of coincident AD and OCD, as well as the response to fluvoxamine, are discussed with respect to nosology, pathophysiology, and treatment of these disorders.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1990 PMID： 2126264 DOI： 10.1007/bf02216058

Source DB: PubMed Journal: J Autism Dev Disord ISSN： 0162-3257

12 in total

1. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.

Authors: R J SCHAIN; D X FREEDMAN
Journal: J Pediatr Date: 1961-03 Impact factor: 4.406

2. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.

Authors: P A McBride; G M Anderson; M E Hertzig; J A Sweeney; J Kream; D J Cohen; J J Mann
Journal: Arch Gen Psychiatry Date: 1989-03

3. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.

Authors: D S Charney; W K Goodman; L H Price; S W Woods; S A Rasmussen; G R Heninger
Journal: Arch Gen Psychiatry Date: 1988-02

Review 4. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction.

Authors: J L Rapoport; S P Wise
Journal: Psychopharmacol Bull Date: 1988

5. Autistic children as adults: psychiatric, social, and behavioral outcomes.

Authors: J M Rumsey; J L Rapoport; W R Sceery
Journal: J Am Acad Child Psychiatry Date: 1985-07

6. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.

Authors: Y D Lapierre; R B Rastogi; R L Singhal
Journal: Neuropsychobiology Date: 1983 Impact factor: 2.328

7. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis.

Authors: T R Insel; H S Akiskal
Journal: Am J Psychiatry Date: 1986-12 Impact factor: 18.112

8. Childhood autism from the point of view of behavioral neurology.

Authors: R G Maurer; A R Damasio
Journal: J Autism Dev Disord Date: 1982-06

9. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Authors: L R Baxter; M E Phelps; J C Mazziotta; B H Guze; J M Schwartz; C E Selin
Journal: Arch Gen Psychiatry Date: 1987-03

Review 7. Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician.

Authors: Ervin Davis; Sy Atezaz Saeed; Diana J Antonacci
Journal: Psychiatr Q Date: 2008-08-23

Review 8. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors: Carolyn A Doyle; Christopher J McDougle
Journal: Dialogues Clin Neurosci Date: 2012-09 Impact factor: 5.986

8 in total

Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report.

1. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.

2. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.

3. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.

Review 4. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction.

5. Autistic children as adults: psychiatric, social, and behavioral outcomes.

6. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.

7. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis.

8. Childhood autism from the point of view of behavioral neurology.

9. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

10. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

1. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

2. Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

3. Brief report: comorbid psychiatric disorders of autistic disorder.

4. Comorbidity of autistic disorder in children and adolescents.

5. Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial.

6. An examination of the phenomenology and the reliability of ratings of compulsive behavior in autism.

Review 7. Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician.

Review 8. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.